MXCT vs TYL · rev $38.6M vs P/E 89, rev $2.14B
MaxCyte Inc (MXCT) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported TYL revenue for 2024-12-31 was $2.14B. Net income was $263.0M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
MXCT currently screens at market cap $124.3M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the MXCT and TYL stock pages for the full models.
Not investment advice.